Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group

Tools

Item Type:	Letter
Title:	Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
Creators Name:	Theis, F., Corbacioglu, A., Gaidzik, V.I., Paschka, P., Weber, D., Bullinger, L., Heuser, M., Ganser, A., Thol, F., Schlegelberger, B., Göhring, G., Köhne, C.H., Germing, U., Brossart, P., Horst, H.A., Haase, D., Götze, K., Ringhoffer, M., Fiedler, W., Nachbaur, D., Kindler, T., Held, G., Lübbert, M., Wattad, M., Salih, H.R., Krauter, J., Döhner, H., Schlenk, R.F. and Döhner, K.
Keywords:	Acute Myeloid Leukemia, CCAAT-Enhancer-Binding Proteins, Cohort Studies, GATA2 Transcription Factor, Mutation, Young Adult
Source:	Leukemia
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Volume:	30
Number:	11
Page Range:	2248-2250
Date:	November 2016
Official Publication:	https://doi.org/10.1038/leu.2016.185
PubMed:	View item in PubMed

Repository Staff Only: item control page